Compendium of Cancer Genome Aberrations

Changes

Volunteer Assignments and Opportunities (view source)

Revision as of 12:34, 22 January 2023

50 bytes removed ,  12:34, 22 January 2023
no edit summary
Line 2,580: Line 2,580:  
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
−
|- |Astrocytoma, IDH-mutant||Disease||
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
   
|-
 
|-
−
|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease||
+
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||
 
|
 
|
 
|
 
|
Line 2,598: Line 2,590:  
|
 
|
 
|-
 
|-
−
|Glioblastoma, IDH-wildtype||Disease||
+
|Glioblastoma, IDH-Wildtype||Disease||
 
|
 
|
 
|
 
|
Line 2,607: Line 2,599:  
|
 
|
 
|-
 
|-
−
|Diffuse astrocytoma, MYB- or MYBL1-altered||Disease||
+
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||
 
|
 
|
 
|
 
|
Line 2,616: Line 2,608:  
|
 
|
 
|-
 
|-
−
|Angiocentric glioma||Disease||
+
|Angiocentric Glioma||Disease||
 
|
 
|
 
|
 
|
Line 2,625: Line 2,617:  
|
 
|
 
|-
 
|-
−
|Polymorphous low-grade neuroepithelial tumour of the young||Disease||
+
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
 
|
 
|
 
|
 
|
Line 2,634: Line 2,626:  
|
 
|
 
|-
 
|-
−
|Diffuse low-grade glioma, MAPK pathway-altered||Disease||
+
|Diffuse Low-Grade Glioma, MAPK Pathway-Altered||Disease||
 
|
 
|
 
|
 
|
Line 2,643: Line 2,635:  
|
 
|
 
|-
 
|-
−
|Diffuse midline glioma, H3 K27-altered||Disease||
+
|Diffuse Midline Glioma, H3 K27-Altered||Disease||
 
|
 
|
 
|
 
|
Line 2,652: Line 2,644:  
|
 
|
 
|-
 
|-
−
|Diffuse hemispheric glioma, H3 G34-mutant||Disease||
+
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||
 
|
 
|
 
|
 
|
Line 2,661: Line 2,653:  
|
 
|
 
|-
 
|-
−
|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease||
+
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||
 
|
 
|
 
|
 
|
Line 2,670: Line 2,662:  
|
 
|
 
|-
 
|-
−
|Infant-type hemispheric glioma||Disease||
+
|Infant-Type Hemispheric  Glioma||Disease||
 
|
 
|
 
|
 
|
Line 2,679: Line 2,671:  
|
 
|
 
|-
 
|-
−
|Pilocytic astrocytoma||Disease||
+
|Pilocytic Astrocytoma||Disease||
 
|
 
|
 
|
 
|
Line 2,688: Line 2,680:  
|
 
|
 
|-
 
|-
−
|High-grade astrocytoma with piloid features||Disease||
+
|High-Grade Astrocytoma with Piloid Features||Disease||
 
|
 
|
 
|
 
|
Line 2,697: Line 2,689:  
|
 
|
 
|-
 
|-
−
|Pleomorphic xanthoastrocytoma||Disease||
+
|Pleomorphic Xanthoastrocytoma||Disease||
 
|
 
|
 
|
 
|
Line 2,706: Line 2,698:  
|
 
|
 
|-
 
|-
−
|Subependymal giant cell astrocytoma||Disease||
+
|Subependymal Giant Cell Astrocytoma||Disease||
 
|
 
|
 
|
 
|
Line 2,715: Line 2,707:  
|
 
|
 
|-
 
|-
−
|Chordoid glioma||Disease||
+
|Chordoid Glioma||Disease||
 
|
 
|
 
|
 
|
Line 2,724: Line 2,716:  
|
 
|
 
|-
 
|-
−
|Astroblastoma, MN1-altered||Disease||
+
|Astroblastoma, MN1-Altered||Disease||
 
|
 
|
 
|
 
|
Line 2,751: Line 2,743:  
|
 
|
 
|-
 
|-
−
|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease||
+
|Desmoplastic Infantile  Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
 
|
 
|
 
|
 
|
Line 2,760: Line 2,752:  
|
 
|
 
|-
 
|-
−
|Dysembryoplastic neuroepithelial tumour||Disease||
+
|Dysembryoplastic Neuroepithelial Tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,769: Line 2,761:  
|
 
|
 
|-
 
|-
−
|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease||
+
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
 
|
 
|
 
|
 
|
Line 2,778: Line 2,770:  
|
 
|
 
|-
 
|-
−
|Papillary glioneuronal tumour||Disease||
+
|Papillary Glioneuronal Tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,787: Line 2,779:  
|
 
|
 
|-
 
|-
−
|Rosette-forming glioneuronal tumour||Disease||
+
|Rosette-Forming Glioneuronal Tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,796: Line 2,788:  
|
 
|
 
|-
 
|-
−
|Myxoid glioneuronal tumour||Disease||
+
|Myxoid Glioneuronal Tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,805: Line 2,797:  
|
 
|
 
|-
 
|-
−
|Diffuse leptomeningeal glioneuronal tumour||Disease||
+
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,814: Line 2,806:  
|
 
|
 
|-
 
|-
−
|Multinodular and vacuolating neuronal tumour||Disease||
+
|Multinodular and Vacuolating Neuronal Tumour||Disease||
 
|
 
|
 
|
 
|
Line 2,823: Line 2,815:  
|
 
|
 
|-
 
|-
−
|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease||
+
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
 
|
 
|
 
|
 
|
Line 2,832: Line 2,824:  
|
 
|
 
|-
 
|-
−
|Central neurocytoma||Disease||
+
|Central Neurocytoma||Disease||
 
|
 
|
 
|
 
|
Line 2,841: Line 2,833:  
|
 
|
 
|-
 
|-
−
|Extraventricular neurocytoma||Disease||
+
|Extraventricular Neurocytoma||Disease||
 
|
 
|
 
|
 
|
Line 2,850: Line 2,842:  
|
 
|
 
|-
 
|-
−
|Cerebellar liponeurocytoma||Disease||
+
|Cerebellar Liponeurocytoma||Disease||
 
|
 
|
 
|
 
|
Line 2,859: Line 2,851:  
|
 
|
 
|-
 
|-
−
|Supratentorial ependymoma||Disease||
+
|Supratentorial Ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 2,868: Line 2,860:  
|
 
|
 
|-
 
|-
−
|Supratentorial ependymoma, ZFTA fusion-positive||Disease||
+
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
 
|
 
|
 
|
 
|
Line 2,877: Line 2,869:  
|
 
|
 
|-
 
|-
−
|Supratentorial ependymoma, YAP1 fusion-positive||Disease||
+
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
 
|
 
|
 
|
 
|
Line 2,886: Line 2,878:  
|
 
|
 
|-
 
|-
−
|Posterior fossa ependymoma||Disease||
+
|Posterior Fossa Ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 2,895: Line 2,887:  
|
 
|
 
|-
 
|-
−
|Posterior fossa group A (PFA) ependymoma||Disease||
+
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 2,904: Line 2,896:  
|
 
|
 
|-
 
|-
−
|Posterior fossa group B (PFB) ependymoma||Disease||
+
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 2,913: Line 2,905:  
|
 
|
 
|-
 
|-
−
|Spinal ependymoma||Disease||
+
|Spinal Ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 2,922: Line 2,914:  
|
 
|
 
|-
 
|-
−
|Spinal ependymoma, MYCN-amplified||Disease||
+
|Spinal Ependymoma, MYCN-Amplified||Disease||
 
|
 
|
 
|
 
|
Line 2,931: Line 2,923:  
|
 
|
 
|-
 
|-
−
|Myxopapillary ependymoma||Disease||
+
|Myxopapillary Ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 2,949: Line 2,941:  
|
 
|
 
|-
 
|-
−
|Choroid plexus papilloma||Disease||
+
|Choroid Plexus Papilloma||Disease||
 
|
 
|
 
|
 
|
Line 2,958: Line 2,950:  
|
 
|
 
|-
 
|-
−
|Atypical choroid plexus papilloma||Disease||
+
|Atypical Choroid Plexus Papilloma||Disease||
 
|
 
|
 
|
 
|
Line 2,967: Line 2,959:  
|
 
|
 
|-
 
|-
−
|Choroid plexus carcinoma||Disease||
+
|Choroid Plexus Carcinoma||Disease||
 
|
 
|
 
|
 
|
Line 2,976: Line 2,968:  
|
 
|
 
|-
 
|-
−
|Medulloblastoma, WNT-activated||Disease||
+
|Medulloblastoma, WNT-Activated||Disease||
 
|
 
|
 
|
 
|
Line 2,985: Line 2,977:  
|
 
|
 
|-
 
|-
−
|Medulloblastoma, SHH-activated and TP53-wildtype||Disease||
+
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
 
|
 
|
 
|
 
|
Line 2,994: Line 2,986:  
|
 
|
 
|-
 
|-
−
|Medulloblastoma, SHH-activated and TP53-mutant||Disease||
+
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
 
|
 
|
 
|
 
|
Line 3,003: Line 2,995:  
|
 
|
 
|-
 
|-
−
|Medulloblastoma, non-WNT/non-SHH||Disease||
+
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
 
|
 
|
 
|
 
|
Line 3,012: Line 3,004:  
|
 
|
 
|-
 
|-
−
|Medulloblastoma, histologically defined||Disease||
+
|Medulloblastoma, Histologically Defined||Disease||
 
|
 
|
 
|
 
|
Line 3,021: Line 3,013:  
|
 
|
 
|-
 
|-
−
|Atypical teratoid/rhabdoid tumour||Disease||
+
|Atypical Teratoid/Rhabdoid Tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,030: Line 3,022:  
|
 
|
 
|-
 
|-
−
|Cribriform neuroepithelial tumour||Disease||
+
|Cribriform Neuroepithelial Tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,039: Line 3,031:  
|
 
|
 
|-
 
|-
−
|Embryonal tumour with multilayered rosettes||Disease||
+
|Embryonal Tumour with Multilayered Rosettes||Disease||
 
|
 
|
 
|
 
|
Line 3,048: Line 3,040:  
|
 
|
 
|-
 
|-
−
|CNS neuroblastoma, FOXR2-activated||Disease||
+
|CNS Neuroblastoma, FOXR2-Activated||Disease||
 
|
 
|
 
|
 
|
Line 3,057: Line 3,049:  
|
 
|
 
|-
 
|-
−
|CNS tumour with BCOR internal tandem duplication||Disease||
+
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
 
|
 
|
 
|
 
|
Line 3,066: Line 3,058:  
|
 
|
 
|-
 
|-
−
|CNS embryonal tumour NEC/NOS||Disease||
+
|CNS Embryonal Tumour NEC/NOS||Disease||
 
|
 
|
 
|
 
|
Line 3,084: Line 3,076:  
|
 
|
 
|-
 
|-
−
|Pineal parenchymal tumour of intermediate differentiation||Disease||
+
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
 
|
 
|
 
|
 
|
Line 3,102: Line 3,094:  
|
 
|
 
|-
 
|-
−
|Papillary tumour of the pineal region||Disease||
+
|Papillary Tumour of the Pineal Region||Disease||
 
|
 
|
 
|
 
|
Line 3,111: Line 3,103:  
|
 
|
 
|-
 
|-
−
|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease||
+
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
 
|
 
|
 
|
 
|
Line 3,147: Line 3,139:  
|
 
|
 
|-
 
|-
−
|Hybrid nerve sheath tumours||Disease||
+
|Hybrid Nerve Sheath Tumours||Disease||
 
|
 
|
 
|
 
|
Line 3,156: Line 3,148:  
|
 
|
 
|-
 
|-
−
|Malignant melanotic nerve sheath tumour||Disease||
+
|Malignant Melanotic Nerve Sheath Tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,165: Line 3,157:  
|
 
|
 
|-
 
|-
−
|Malignant peripheral nerve sheath tumour||Disease||
+
|Malignant Peripheral Nerve Sheath Tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,174: Line 3,166:  
|
 
|
 
|-
 
|-
−
|Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease||
+
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
 
|
 
|
 
|
 
|
Line 3,192: Line 3,184:  
|
 
|
 
|-
 
|-
−
|Solitary fibrous tumour||Disease||
+
|Solitary Fibrous Tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,201: Line 3,193:  
|
 
|
 
|-
 
|-
−
|Haemangiomas and vascular malformations||Disease||
+
|Haemangiomas and Vascular Malformations||Disease||
 
|
 
|
 
|
 
|
Line 3,228: Line 3,220:  
|
 
|
 
|-
 
|-
−
|Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease||
+
|Intracranial Mesenchymal  Tumour, FET::CREB Fusion-Positive||Disease||
 
|
 
|
 
|
 
|
Line 3,237: Line 3,229:  
|
 
|
 
|-
 
|-
−
|CIC-rearranged sarcoma||Disease||
+
|CIC-Rearranged Sarcoma||Disease||
 
|
 
|
 
|
 
|
Line 3,246: Line 3,238:  
|
 
|
 
|-
 
|-
−
|Primary intracranial sarcoma, DICER1-mutant||Disease||
+
|Primary Intracranial  Sarcoma, DICER1-Mutant||Disease||
 
|
 
|
 
|
 
|
Line 3,255: Line 3,247:  
|
 
|
 
|-
 
|-
−
|Ewing sarcoma||Disease||
+
|Ewing Sarcoma||Disease||
 
|
 
|
 
|
 
|
Line 3,264: Line 3,256:  
|
 
|
 
|-
 
|-
−
|Mesenchymal chondrosarcoma||Disease||
+
|Mesenchymal Chondrosarcoma||Disease||
 
|
 
|
 
|
 
|
Line 3,291: Line 3,283:  
|
 
|
 
|-
 
|-
−
|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease||
+
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
 
|
 
|
 
|
 
|
Line 3,300: Line 3,292:  
|
 
|
 
|-
 
|-
−
|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease||
+
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
 
|
 
|
 
|
 
|
Line 3,309: Line 3,301:  
|
 
|
 
|-
 
|-
−
|Primary diffuse large B-cell lymphoma of the CNS||Disease||
+
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
 
|
 
|
 
|
 
|
Line 3,318: Line 3,310:  
|
 
|
 
|-
 
|-
−
|Immunodeficiency-associated CNS lymphomas||Disease||
+
|Immunodeficiency-Associated CNS Lymphomas||Disease||
 
|
 
|
 
|
 
|
Line 3,327: Line 3,319:  
|
 
|
 
|-
 
|-
−
|Lymphomatoid granulomatosis||Disease||
+
|Lymphomatoid Granulomatosis||Disease||
 
|
 
|
 
|
 
|
Line 3,336: Line 3,328:  
|
 
|
 
|-
 
|-
−
|Intravascular large B-cell lymphoma||Disease||
+
|Intravascular Large B-cell Lymphoma||Disease||
 
|
 
|
 
|
 
|
Line 3,345: Line 3,337:  
|
 
|
 
|-
 
|-
−
|MALT lymphoma of the dura||Disease||
+
|MALT Lymphoma of the Dura||Disease||
 
|
 
|
 
|
 
|
Line 3,354: Line 3,346:  
|
 
|
 
|-
 
|-
−
|Other low-grade B-cell lymphomas of the CNS||Disease||
+
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
 
|
 
|
 
|
 
|
Line 3,363: Line 3,355:  
|
 
|
 
|-
 
|-
−
|Anaplastic large cell lymphoma (ALK+/ALK−)||Disease||
+
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||
 
|
 
|
 
|
 
|
Line 3,372: Line 3,364:  
|
 
|
 
|-
 
|-
−
|T-cell and NK/T-cell lymphomas||Disease||
+
|T-cell and NK/T-cell Lymphomas||Disease||
 
|
 
|
 
|
 
|
Line 3,381: Line 3,373:  
|
 
|
 
|-
 
|-
−
|Erdheim-Chester disease||Disease||
+
|Erdheim-Chester Disease||Disease||
 
|
 
|
 
|
 
|
Line 3,390: Line 3,382:  
|
 
|
 
|-
 
|-
−
|Rosai-Dorfman disease||Disease||
+
|Rosai-Dorfman Disease||Disease||
 
|
 
|
 
|
 
|
Line 3,399: Line 3,391:  
|
 
|
 
|-
 
|-
−
|Juvenile xanthogranuloma||Disease||
+
|Juvenile Xanthogranuloma||Disease||
 
|
 
|
 
|
 
|
Line 3,408: Line 3,400:  
|
 
|
 
|-
 
|-
−
|Langerhans cell histiocytosis||Disease||
+
|Langerhans Cell Histiocytosis||Disease||
 
|
 
|
 
|
 
|
Line 3,417: Line 3,409:  
|
 
|
 
|-
 
|-
−
|Histiocytic sarcoma||Disease||
+
|Histiocytic Sarcoma||Disease||
 
|
 
|
 
|
 
|
Line 3,426: Line 3,418:  
|
 
|
 
|-
 
|-
−
|Germ cell tumours of the CNS||Disease||
+
|Germ Cell Tumours of the CNS||Disease||
 
|
 
|
 
|
 
|
Line 3,435: Line 3,427:  
|
 
|
 
|-
 
|-
−
|Adamantinomatous craniopharyngioma||Disease||
+
|Adamantinomatous Craniopharyngioma||Disease||
 
|
 
|
 
|
 
|
Line 3,444: Line 3,436:  
|
 
|
 
|-
 
|-
−
|Papillary craniopharyngioma||Disease||
+
|Papillary Craniopharyngioma||Disease||
 
|
 
|
 
|
 
|
Line 3,453: Line 3,445:  
|
 
|
 
|-
 
|-
−
|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease||
+
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
 
|
 
|
 
|
 
|
Line 3,462: Line 3,454:  
|
 
|
 
|-
 
|-
−
|Pituitary adenoma / pituitary neuroendocrine tumour||Disease||
+
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,471: Line 3,463:  
|
 
|
 
|-
 
|-
−
|Pituitary blastoma||Disease||
+
|Pituitary Blastoma||Disease||
 
|
 
|
 
|
 
|
Line 3,480: Line 3,472:  
|
 
|
 
|-
 
|-
−
|Metastases to the brain and spinal cord parenchyma||Disease||
+
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
 
|
 
|
 
|
 
|
Line 3,489: Line 3,481:  
|
 
|
 
|-
 
|-
−
|Metastases to the meninges||Disease||
+
|Metastases to the Meninges||Disease||
 
|
 
|
 
|
 
|
Line 3,498: Line 3,490:  
|
 
|
 
|-
 
|-
−
|Neurofibromatosis type 1||Disease||
+
|Neurofibromatosis Type 1||Disease||
 
|
 
|
 
|
 
|
Line 3,507: Line 3,499:  
|
 
|
 
|-
 
|-
−
|Neurofibromatosis type 2||Disease||
+
|Neurofibromatosis Type 2||Disease||
 
|
 
|
 
|
 
|
Line 3,525: Line 3,517:  
|
 
|
 
|-
 
|-
−
|Von Hippel-Lindau syndrome||Disease||
+
|Von Hippel-Lindau Syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,534: Line 3,526:  
|
 
|
 
|-
 
|-
−
|Tuberous sclerosis||Disease||
+
|Tuberous Sclerosis||Disease||
 
|
 
|
 
|
 
|
Line 3,543: Line 3,535:  
|
 
|
 
|-
 
|-
−
|Li-Fraumeni syndrome||Disease||
+
|Li-Fraumeni Syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,552: Line 3,544:  
|
 
|
 
|-
 
|-
−
|Cowden syndrome||Disease||
+
|Cowden Syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,561: Line 3,553:  
|
 
|
 
|-
 
|-
−
|Constitutional mismatch repair deficiency syndrome||Disease||
+
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,570: Line 3,562:  
|
 
|
 
|-
 
|-
−
|Familial adenomatous polyposis 1||Disease||
+
|Familial Adenomatous Polyposis 1||Disease||
 
|
 
|
 
|
 
|
Line 3,579: Line 3,571:  
|
 
|
 
|-
 
|-
−
|Naevoid basal cell carcinoma syndrome||Disease||
+
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,588: Line 3,580:  
|
 
|
 
|-
 
|-
−
|Rhabdoid tumour predisposition syndrome||Disease||
+
|Rhabdoid Tumour Predisposition Syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,597: Line 3,589:  
|
 
|
 
|-
 
|-
−
|Carney complex||Disease||
+
|Carney Complex||Disease||
 
|
 
|
 
|
 
|
Line 3,606: Line 3,598:  
|
 
|
 
|-
 
|-
−
|DICER1 syndrome||Disease||
+
|DICER1 Syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,615: Line 3,607:  
|
 
|
 
|-
 
|-
−
|Familial paraganglioma syndromes||Disease||
+
|Familial Paraganglioma Syndromes||Disease||
 
|
 
|
 
|
 
|
Line 3,624: Line 3,616:  
|
 
|
 
|-
 
|-
−
|Melanoma-astrocytoma syndrome||Disease||
+
|Melanoma-Astrocytoma Syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,633: Line 3,625:  
|
 
|
 
|-
 
|-
−
|Familial retinoblastoma||Disease||
+
|Familial Retinoblastoma||Disease||
 
|
 
|
 
|
 
|
Line 3,642: Line 3,634:  
|
 
|
 
|-
 
|-
−
|BAP1 tumour predisposition syndrome||Disease||
+
|BAP1 Tumour Predisposition Syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,651: Line 3,643:  
|
 
|
 
|-
 
|-
−
|Fanconi anaemia||Disease||
+
|Fanconi Anaemia||Disease||
 
|
 
|
 
|
 
|
Line 3,660: Line 3,652:  
|
 
|
 
|-
 
|-
−
|ELP1-medulloblastoma syndrome||Disease||
+
|ELP1-Medulloblastoma Syndrome||Disease||
 
|
 
|
 
|
 
|
Retrieved from "https://ccga.io/index.php/Special:MobileDiff/11746"